TON - August 2022 Vol 15, No 4

According to data from the American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry, black or African-American patients with cancer and COVID-19 were more likely than non-Hispanic white patients to experience delays or disruptions in cancer treatment during the pandemic. Read More ›

This section provides a brief overview of FDA news related to cancer drugs, including new drugs and new indications approved by the FDA between June 22, 2022, and July 14, 2022. Read More ›